GW Pharmaceuticals Added to Nasdaq Biotech Index
GW Pharmaceuticals, a United Kingdom-based company that develops CBD-rich treatments, has been added to the Nasdaq Biotechnology Index…
News December 23
Latest In: GW Pharmaceuticals
UK Company Raising $148M to Advance CBD Drug
British drug maker GW Pharmaceuticals plans to raise $148 million from U.S. investors to advance an epilepsy drug…
News June 20Featured
1
Latest Sponsored
